With 40 years of experience within multinational Research & Development organizations including Novo Industri, Novo Nordisk and Novozymes, Per Falholt has significant experience with global partnerships and co-development of new product offerings. His experience includes working extensively with mergers and acquisitions of both companies and new technologies.
During the course of his career Per has launched more than 200 new biotech products to the market and possesses deep insight in selection and development of production strains and effective biological production systems.
Per is an experienced board member with Chairmanship positions at the DHI Foundation and Universe. He is a Member of the Board at Danfoss and a former Chair at DTU.
